Intravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion

PURPOSE: To assess the efficacy of intravitreal Pegaptanib sodium (Macugen(®)) injection in the management of refractory macular edema secondary to branch retinal vein occlusion. METHODS: This is a prospective, nonrandomized, interventional case series. Five eyes of five patients with macular edema...

Descripción completa

Detalles Bibliográficos
Autores principales: Udaondo, Patricia, Garcia-Delpech, Salvador, Salom, David, Garcia-Pous, Maria, Diaz-Llopis, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141857/
https://www.ncbi.nlm.nih.gov/pubmed/21792283
http://dx.doi.org/10.2147/OPTH.S18873
_version_ 1782208768918945792
author Udaondo, Patricia
Garcia-Delpech, Salvador
Salom, David
Garcia-Pous, Maria
Diaz-Llopis, Manuel
author_facet Udaondo, Patricia
Garcia-Delpech, Salvador
Salom, David
Garcia-Pous, Maria
Diaz-Llopis, Manuel
author_sort Udaondo, Patricia
collection PubMed
description PURPOSE: To assess the efficacy of intravitreal Pegaptanib sodium (Macugen(®)) injection in the management of refractory macular edema secondary to branch retinal vein occlusion. METHODS: This is a prospective, nonrandomized, interventional case series. Five eyes of five patients with macular edema refractory to either bevacizumab or triamcinolone were treated with intravitreal injection of Pegaptanib sodium. RESULTS: After three months follow-up, both visual acuity and macular edema, measured by optical coherence tomography and fluorescence angiography, dramatically improved. CONCLUSION: Pegaptanib sodium is a safe and efficacy treatment for macular edema secondary to branch retinal vein occlusion.
format Online
Article
Text
id pubmed-3141857
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-31418572011-07-26 Intravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion Udaondo, Patricia Garcia-Delpech, Salvador Salom, David Garcia-Pous, Maria Diaz-Llopis, Manuel Clin Ophthalmol Case Report PURPOSE: To assess the efficacy of intravitreal Pegaptanib sodium (Macugen(®)) injection in the management of refractory macular edema secondary to branch retinal vein occlusion. METHODS: This is a prospective, nonrandomized, interventional case series. Five eyes of five patients with macular edema refractory to either bevacizumab or triamcinolone were treated with intravitreal injection of Pegaptanib sodium. RESULTS: After three months follow-up, both visual acuity and macular edema, measured by optical coherence tomography and fluorescence angiography, dramatically improved. CONCLUSION: Pegaptanib sodium is a safe and efficacy treatment for macular edema secondary to branch retinal vein occlusion. Dove Medical Press 2011 2011-07-07 /pmc/articles/PMC3141857/ /pubmed/21792283 http://dx.doi.org/10.2147/OPTH.S18873 Text en © 2011 Udaondo et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Case Report
Udaondo, Patricia
Garcia-Delpech, Salvador
Salom, David
Garcia-Pous, Maria
Diaz-Llopis, Manuel
Intravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion
title Intravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion
title_full Intravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion
title_fullStr Intravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion
title_full_unstemmed Intravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion
title_short Intravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion
title_sort intravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141857/
https://www.ncbi.nlm.nih.gov/pubmed/21792283
http://dx.doi.org/10.2147/OPTH.S18873
work_keys_str_mv AT udaondopatricia intravitrealpegaptanibforrefractorymacularedemasecondarytoretinalveinocclusion
AT garciadelpechsalvador intravitrealpegaptanibforrefractorymacularedemasecondarytoretinalveinocclusion
AT salomdavid intravitrealpegaptanibforrefractorymacularedemasecondarytoretinalveinocclusion
AT garciapousmaria intravitrealpegaptanibforrefractorymacularedemasecondarytoretinalveinocclusion
AT diazllopismanuel intravitrealpegaptanibforrefractorymacularedemasecondarytoretinalveinocclusion

Ejemplares similares